Monsanto Co., founded in 1901 and headquartered in St. Louis, Missouri, is a global leader in biotechnology and agricultural products, dedicated to sustainable solutions for agriculture. The company focuses on the development and commercialization of genetically modified seeds and crop protection chemicals, aimed at enhancing agricultural productivity and addressing food security challenges.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| MON 2.85% 2025-04-15 USDMonsanto Co. | United States | 2025-04-15 | 2.850 | 0.00 |
| MON 3.60% 2042-07-15 USDMonsanto Co. | United States | 2042-07-15 | 3.600 | 7.58 |
| MON 3.95% 2045-04-15 USDMonsanto Co. | United States | 2045-04-15 | 3.950 | 7.58 |
| MON 4.20% 2034-07-15 USDMonsanto Co. | United States | 2034-07-15 | 4.200 | 5.71 |
| MON 4.40% 2044-07-15 USDMonsanto Co. | United States | 2044-07-15 | 4.400 | 6.94 |
| MON 4.65% 2043-11-15 USDMonsanto Co. | United States | 2043-11-15 | 4.650 | 6.82 |
| MON 4.70% 2064-07-15 USDMonsanto Co. | United States | 2064-07-15 | 4.700 | 7.31 |
| MON 5.50% 2025-08-15 USDMonsanto Co. | United States | 2025-08-15 | 5.500 | 0.00 |
| MON 5.50% 2035-07-30 USDMonsanto Co. | United States | 2035-07-30 | 5.500 | 5.69 |
| MON 5.88% 2038-04-15 USDMonsanto Co. | United States | 2038-04-15 | 5.875 | 6.32 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Monsanto began issuing bonds in the late 1990s to support its growing operations and expansion in the agricultural sector. A notable issuance occurred in 2018 when the company issued $1 billion in bonds, which were used to finance their acquisition by Bayer AG. Current yields on Monsanto's bonds are competitive within the sector, reflecting its solid market position and growth strategy. The bonds have features such as call provisions that offer flexibility in managing debt, contributing to the company’s financial strategy during market fluctuations.